Literature DB >> 2563002

Hearing impairment in patients with antibody production against Borrelia burgdorferi antigen.

P Hanner1, U Rosenhall, S Edström, B Kaijser.   

Abstract

This study aimed to evaluate the extent to which hearing disorders may be a result of tick-borne Borrelia burgdorferi infection. 98 patients with different patterns of hearing dysfunction were studied. The patients had a history of sudden hearing loss, disorders similar to Menière's disease, or hearing loss in combination with acute facial palsy or with vertigo. Serum antibodies against the B burgdorferi antigen were determined during the acute and convalescent periods. 17 patients (17%) showed serological evidence of borreliosis (reciprocal titre of 320 or above). All but 3 of these patients also had vertigo and 3 subjects had peripheral facial palsy. All the 17 patients were treated with high doses of intravenous benzylpenicillin. The hearing of 5 patients improved on treatment. Although the specificity of antibody production against borrelia antigen has not been completely clarified, it is concluded that repeated serological examinations are worthwhile in patients with unexplained hearing disorders.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563002     DOI: 10.1016/s0140-6736(89)91673-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

1.  The fast of Ramadan.

Authors:  A H Rashed
Journal:  BMJ       Date:  1992-02-29

2.  [Sensorineural loss of hearing in lower registers as the main symptom of Lyme disease].

Authors:  K Mehler; M Emmel; H F Petereit; A Sprüth; A Dröge; K Brockmeier
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

3.  Patients with non-idiopathic sudden sensorineural hearing loss show hearing improvement more often than patients with idiopathic sudden sensorineural hearing loss.

Authors:  Jovanna Thielker; Anne Heuschkel; Daniel Boeger; Jens Buentzel; Dirk Esser; Kerstin Hoffmann; Peter Jecker; Andreas Mueller; Gerald Radtke; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-03-08       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.